GENEVA, Sept 24: The World Health Organization (WHO) confirmed Wednesday that there is no conclusive scientific evidence to suggest a link between autism and the use of paracetamol (acetaminophen) during pregnancy.

This statement comes in response to recent comments by US President Donald Trump, who linked the use of paracetamol by pregnant women to autism. The Geneva-based health body issued a press release, emphasizing that extensive research over the past decade has found no such connection.

WHO pointed out that approximately 62 million people globally, or one in every 127 individuals, are affected by autism. While the exact causes of autism remain unclear, the organization noted that multiple factors are likely involved in its development.

In addition, WHO reiterated that major studies have firmly refuted any connection between paracetamol use during pregnancy and autism. It also stressed that substantial scientific evidence has debunked claims that childhood vaccines contribute to autism. Large-scale studies conducted across various countries have consistently shown no such link since the late 1990s, according to the WHO.

The organization emphasized that while vaccines do not cause autism or other developmental disorders, pregnant women must follow medical advice regarding medication use. WHO particularly highlighted the importance of caution during the first trimester of pregnancy, urging women to consult healthcare professionals before using any medications.

Furthermore, WHO reinforced the life-saving benefits of childhood vaccination schedules, which are based on robust scientific research. These vaccination schedules have been credited with saving at least 154 million lives over the past five decades and continue to protect individuals and communities from 30 infectious diseases.

The issue of autism and neurodevelopmental disorders will be a key focus at the upcoming Fourth United Nations High-Level Meeting on Noncommunicable Diseases and Mental Health, set to take place in New York on Thursday. WHO reaffirmed its commitment to advancing research on autism causes and improving support for individuals with autism and their families, in collaboration with organizations led by people with autism and those representing lived experiences.